15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells

BackgroundPrematurity is the leading cause of childhood death under the age of five. The aetiology of preterm birth is multifactorial; however, inflammation and infection are the most common causal factors, supporting a potential role for immunomodulation as a therapeutic strategy. 15-Deoxy-Delta-12...

Full description

Bibliographic Details
Main Authors: Zahirrah BM. Rasheed, Yun S. Lee, Sung H. Kim, Tg Teoh, David A. MacIntyre, Phillip R. Bennett, Lynne Sykes
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.983924/full
_version_ 1798031869925654528
author Zahirrah BM. Rasheed
Zahirrah BM. Rasheed
Yun S. Lee
Yun S. Lee
Sung H. Kim
Sung H. Kim
Tg Teoh
Tg Teoh
Tg Teoh
David A. MacIntyre
David A. MacIntyre
Phillip R. Bennett
Phillip R. Bennett
Lynne Sykes
Lynne Sykes
Lynne Sykes
author_facet Zahirrah BM. Rasheed
Zahirrah BM. Rasheed
Yun S. Lee
Yun S. Lee
Sung H. Kim
Sung H. Kim
Tg Teoh
Tg Teoh
Tg Teoh
David A. MacIntyre
David A. MacIntyre
Phillip R. Bennett
Phillip R. Bennett
Lynne Sykes
Lynne Sykes
Lynne Sykes
author_sort Zahirrah BM. Rasheed
collection DOAJ
description BackgroundPrematurity is the leading cause of childhood death under the age of five. The aetiology of preterm birth is multifactorial; however, inflammation and infection are the most common causal factors, supporting a potential role for immunomodulation as a therapeutic strategy. 15-Deoxy-Delta-12,14-prostaglandin J2 (15dPGJ2) is an anti-inflammatory prostaglandin and has been shown to delay lipopolysaccharide (LPS) induced preterm labour in mice and improve pup survival. This study explores the immunomodulatory effect of 15dPGJ2 on the transcription factors NF-κB and AP-1, pro-inflammatory cytokines, and contraction associated proteins in human cultured myocytes, vaginal epithelial cell line (VECs) and primary amnion epithelial cells (AECs).MethodsCells were pre-incubated with 32µM of 15dPGJ2 and stimulated with 1ng/mL of IL-1β as an in vitro model of inflammation. Western immunoblotting was used to detect phosphorylated p-65 and phosphorylated c-Jun as markers of NF-κB and AP-1 activation, respectively. mRNA expression of the pro-inflammatory cytokines IL-6, IL-8, and TNF-α was examined, and protein expression of COX-2 and PGE2 were detected by western immunoblotting and ELISA respectively. Myometrial contractility was examined ex-vivo using a myograph.Results15dPGJ2 inhibited IL-1β-induced activation of NF-κB and AP-1, and expression of IL-6, IL-8, TNF-α, COX-2 and PGE2 in myocytes, with no effect on myometrial contractility or cell viability. Despite inhibiting IL-1β-induced activation of NF-κB, expression of IL-6, TNF-α, and COX-2, 15dPGJ2 led to activation of AP-1, increased production of PGE2 and increased cell death in VECs and AECs.ConclusionWe conclude that 15dPGJ2 has differential effects on inflammatory modulation depending on cell type and is therefore unlikely to be a useful therapeutic agent for the prevention of preterm birth.
first_indexed 2024-04-11T20:04:35Z
format Article
id doaj.art-61546a994fa14fbc9d592c42200f63a0
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T20:04:35Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-61546a994fa14fbc9d592c42200f63a02022-12-22T04:05:23ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-09-011310.3389/fendo.2022.98392498392415-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cellsZahirrah BM. Rasheed0Zahirrah BM. Rasheed1Yun S. Lee2Yun S. Lee3Sung H. Kim4Sung H. Kim5Tg Teoh6Tg Teoh7Tg Teoh8David A. MacIntyre9David A. MacIntyre10Phillip R. Bennett11Phillip R. Bennett12Lynne Sykes13Lynne Sykes14Lynne Sykes15Imperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomUniversiti Kebangsaan Malaysia (UKM) Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, MalaysiaImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomThe Parasol Foundation Centre for Women’s Health and Cancer Research, St Mary’s Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United KingdomImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomImperial College Parturition Research Group, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United KingdomMarch of Dimes European Preterm Birth Prematurity Research Centre, Imperial College London, London, United KingdomThe Parasol Foundation Centre for Women’s Health and Cancer Research, St Mary’s Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United KingdomBackgroundPrematurity is the leading cause of childhood death under the age of five. The aetiology of preterm birth is multifactorial; however, inflammation and infection are the most common causal factors, supporting a potential role for immunomodulation as a therapeutic strategy. 15-Deoxy-Delta-12,14-prostaglandin J2 (15dPGJ2) is an anti-inflammatory prostaglandin and has been shown to delay lipopolysaccharide (LPS) induced preterm labour in mice and improve pup survival. This study explores the immunomodulatory effect of 15dPGJ2 on the transcription factors NF-κB and AP-1, pro-inflammatory cytokines, and contraction associated proteins in human cultured myocytes, vaginal epithelial cell line (VECs) and primary amnion epithelial cells (AECs).MethodsCells were pre-incubated with 32µM of 15dPGJ2 and stimulated with 1ng/mL of IL-1β as an in vitro model of inflammation. Western immunoblotting was used to detect phosphorylated p-65 and phosphorylated c-Jun as markers of NF-κB and AP-1 activation, respectively. mRNA expression of the pro-inflammatory cytokines IL-6, IL-8, and TNF-α was examined, and protein expression of COX-2 and PGE2 were detected by western immunoblotting and ELISA respectively. Myometrial contractility was examined ex-vivo using a myograph.Results15dPGJ2 inhibited IL-1β-induced activation of NF-κB and AP-1, and expression of IL-6, IL-8, TNF-α, COX-2 and PGE2 in myocytes, with no effect on myometrial contractility or cell viability. Despite inhibiting IL-1β-induced activation of NF-κB, expression of IL-6, TNF-α, and COX-2, 15dPGJ2 led to activation of AP-1, increased production of PGE2 and increased cell death in VECs and AECs.ConclusionWe conclude that 15dPGJ2 has differential effects on inflammatory modulation depending on cell type and is therefore unlikely to be a useful therapeutic agent for the prevention of preterm birth.https://www.frontiersin.org/articles/10.3389/fendo.2022.983924/fullnuclear factor - kappa B (NF - κB)activator protein (AP)-1inflammationcytokinesprostaglandinspreterm labour (PTL)
spellingShingle Zahirrah BM. Rasheed
Zahirrah BM. Rasheed
Yun S. Lee
Yun S. Lee
Sung H. Kim
Sung H. Kim
Tg Teoh
Tg Teoh
Tg Teoh
David A. MacIntyre
David A. MacIntyre
Phillip R. Bennett
Phillip R. Bennett
Lynne Sykes
Lynne Sykes
Lynne Sykes
15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
Frontiers in Endocrinology
nuclear factor - kappa B (NF - κB)
activator protein (AP)-1
inflammation
cytokines
prostaglandins
preterm labour (PTL)
title 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
title_full 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
title_fullStr 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
title_full_unstemmed 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
title_short 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells
title_sort 15 deoxy delta 12 14 prostaglandin j2 modulates pro labour and pro inflammatory responses in human myocytes vaginal and amnion epithelial cells
topic nuclear factor - kappa B (NF - κB)
activator protein (AP)-1
inflammation
cytokines
prostaglandins
preterm labour (PTL)
url https://www.frontiersin.org/articles/10.3389/fendo.2022.983924/full
work_keys_str_mv AT zahirrahbmrasheed 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT zahirrahbmrasheed 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT yunslee 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT yunslee 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT sunghkim 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT sunghkim 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT tgteoh 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT tgteoh 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT tgteoh 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT davidamacintyre 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT davidamacintyre 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT philliprbennett 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT philliprbennett 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT lynnesykes 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT lynnesykes 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells
AT lynnesykes 15deoxydelta1214prostaglandinj2modulatesprolabourandproinflammatoryresponsesinhumanmyocytesvaginalandamnionepithelialcells